Literature DB >> 16458486

Prevalence of subgingival bacteria resistant to aminopenicillins and metronidazole in dental patients from Yemen and Norway.

M H Al-Haroni1, N Skaug, N N Al-Hebshi.   

Abstract

The purpose of this study was to assess the prevalence of resistance to aminopenicillins and metronidazole among selected subgingival species in dental patients from Yemen and Norway. Three subgingival samples were collected by paper points from each of 34 Yemeni and 21 Norwegian adult volunteers and then pooled. Each of the 55 pooled samples was plated on fastidious anaerobic blood agar containing 2 microg/mL ampicillin or metronidazole, or no antimicrobial. Species identification of growth was done using DNA-DNA checkerboard hybridisation. The overall proportion of ampicillin resistance among the 18 identified species was 28.9% and 7.9% in the Yemeni and Norwegian samples, respectively, whereas for metronidazole it was 60.3% and 11.3%. The number of species resistant to ampicillin and metronidazole was significantly higher (P < 0.016 and P = 0.0000, respectively) in the Yemeni than in the Norwegian samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458486     DOI: 10.1016/j.ijantimicag.2005.10.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  Susceptibility of strict and facultative anaerobes Isolated from endodontic infections to metronidazole and beta-lactams.

Authors:  Elerson Gaetti-Jardim Júnior; Luís Fernando Landucci; Samira Ambar Lins; Evanice Menezes Marçal Vieira; Sérgio Ricardo de Oliveira
Journal:  J Appl Oral Sci       Date:  2007-12       Impact factor: 2.698

2.  The effect of metronidazole plus amoxicillin or metronidazole plus penicillin V on periodontal pathogens in an in vitro biofilm model.

Authors:  Gabriela Dabija-Wolter; Sundus Saad Al-Zubaydi; Marwan Mansoor Ali Mohammed; Vidar Bakken; Anne Isine Bolstad
Journal:  Clin Exp Dent Res       Date:  2018-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.